Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas

Journal of Nuclear Medicine

Volumn 37, Issue 9, 1996, Pages 1476-1479

  Garcia, Jose R ^a   Kim, E Edmund ^a,b   Wong, Franklin C L ^a   Korkmaz, Melina ^a   Wong, Wai Hoi ^a   Yang, David J ^a   Podoloff, Donald A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

fluorine 18 fluorodeoxyglucose; PET; sarcomas; SPECT; technetium 99m sestamibi

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYOSARCOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BONE NEOPLASMS; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MUSCLE NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; SARCOMA; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029762287     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Aisen AM, Martel W, Braunstein EM, Phillips WA, Kling TF. MRI and CT evaluation of primary bone and soft-tissue tumors. AJR 1986;146:749-756.
2. Hudson TM, Hamlin DJ, Enneking WF, Pettersson H. Magnetic resonance imaging of bone and soft-tissue tumors: early experience in 31 patients compared with computed tomography. Skeletal Radiol 1985;13:134-146.
3. Petasnick JP, Turner DA, Charters JR, Gitelis S, Zacharias CE. Soft-tissue masses of the locomotor system: comparison of MR imaging with CT. Radiology 1986;160:125-133.
4. Ramanna L, Waxman A, Binney G, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-99m-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990;31:567-572.
5. Podoloff DA, Haynie TP, Kim EE, et al. Thallium-201 SPECT tumor imaging in differentiation of recurrent metastases disease from post-therapy complications. J Nucl Med 1993;32[Abstract]:962.
6. O'Tuama L, Treves S, Larar J, et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: within-subject comparison. J Nucl Med 1991;34:1045-1051.
7. O'Tuama L, Packard A, Treves S. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium (I). J Nucl Med 1990;31:2040-2041.
8. Adler L, Blair H, Makley J, et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991;32:1508-1512.
9. 99mTc-hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989;14:333-340.
10. Caner B, Kitapci M, Unlü M, et al. Technetium-99m-MIBI update in benign and malignant bone lesions: comparative study with technetium-99m-MDP. J Nucl Med 1992;33:319-324.
11. Caner B, Kitapci M, Aras T, Erbengi G, Ugur D, Bekdik C. Increased accumulation of hexatis (2-methoxyisobutylisonityik technetium (I) in osteosarcoma and its metastatic lymph nodes. J Nucl Med 1991;32:1977-1978.
12. Warburg O. On the origin of cancer cells. Science 1956;123:309-314.
13. 18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 1993;33:540-548.
14. Strauss L, Clorius J, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329-332.
15. Griffeth L, Dehdashti F, McGuire A, et al. PET evaluation of soft-tissue masses with fluorine-18-fluoro-2-deoxy-D-glucose. Radiology 1992;182:185-194.
16. Piwnica-Worms D, Chiu ML, Budding M, Kronause JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-984.